REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,953 | -29.5% | 78 | -37.1% | 0.00% | – |
| Q1 2023 | $11,274 | -95.2% | 124 | -98.0% | 0.00% | – |
| Q4 2022 | $233,334 | +80.9% | 6,142 | +19.3% | 0.00% | – |
| Q3 2022 | $129,000 | -88.4% | 5,148 | -87.8% | 0.00% | -100.0% |
| Q4 2021 | $1,108,000 | -73.3% | 42,089 | +2.1% | 0.00% | -71.4% |
| Q3 2021 | $4,145,000 | -17.0% | 41,215 | +16.7% | 0.01% | -12.5% |
| Q2 2021 | $4,996,000 | +453.9% | 35,317 | +510.3% | 0.01% | +300.0% |
| Q2 2020 | $902,000 | +311.9% | 5,787 | +280.0% | 0.00% | +100.0% |
| Q1 2020 | $219,000 | -79.3% | 1,523 | -70.6% | 0.00% | -50.0% |
| Q4 2019 | $1,060,000 | +430.0% | 5,186 | +107.7% | 0.00% | – |
| Q3 2019 | $200,000 | -21.3% | 2,497 | -68.8% | 0.00% | – |
| Q2 2017 | $254,000 | – | 8,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |